Pathophysiology of autoimmune-associated congenital heart block

Applied Cardiopulmonary Pathophysiology

Volumn 16, Issue 1, 2012, Pages 96-112

  Qu, Yongxia ^a,b   Boutjdir, Mohamed ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti ro ssa antibodies; Apoptosis; Atrioventricular block; Ca channels; Neonatal lupus

Indexed keywords

ALPHA 1C ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA ENOLASE; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALRETICULIN; ENDOTHELIN 1; IMMUNOGLOBULIN G; LA ANTIBODY; LAMININ 1; MATERNAL ANTIBODY; RO ANTIBODY; SEROTONIN 4 RECEPTOR; STAUROSPORINE; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; UROKINASE RECEPTOR;

APOPTOSIS; AUTOIMMUNE DISEASE; CALCIFICATION; CARDIOMYOPATHY; CELL DEATH; CELL PHAGOCYTOSIS; CELL SURFACE; COMPLETE HEART BLOCK; CONFOCAL MICROSCOPY; CONGENITAL HEART BLOCK; CROSS REACTION; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXCITATION CONTRACTION COUPLING; FLOW CYTOMETRY; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SARCOLEMMA; SINUS BRADYCARDIA; SINUS NODE; UPREGULATION;

EID: 84857946919     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytio trophoblast: implications for maternal-fetal antibody transport. J Immunol 1996; 157 (8): 3317-3322
2. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Skovron ML. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31 (7): 1658-1666
3. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120 (7): 544-551
4. Silverman ED. Congenital heart block and neonatal lupus erythematosus: prevention is the goal. J Rheumatol 1993; 20 (7): 1101-1104
5. Julkunen H, Kurki P, Kaaja R, Heikkila R, Immonen I, Chan EK, Wallgren E, Friman C. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum. 1993; 36 (11): 1588-1598
6. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991; 17 (6): 1360-1366
7. Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 2009; 5 (3): 139-148
8. Buyon JP, Clancy RM, Friedman DM. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med 2009; 265 (6): 653-662
9. Hamilton RM, Lee-Poy M, Kruger K, Silverman ED. Investigative methods of congenital complete heart block. J Electrocardiol 1998; 30 Suppl: 69-74
10. Menon A, Silverman ED, Gow RM, Hamilton RM. Chronotropic competence of the sinus node in congenital complete heart block. Am J Cardiol 1998; 82 (9): 1119-1121, A1119
11. Brucato A, Cimaz R, Catelli L, Meroni P. Anti- Ro-associated sinus bradycardia in newborns. Circulation 2000; 102 (11): E88-89
12. Motta M, Rodriguez-Perez C, Tincani A, Lojacono A, Chirico G. Outcome of infants from mothers with anti-SSA/Ro antibodies. J Perinatol 2007; 27 (5): 278-283
13. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000; 43 (5): 1049-1053
14. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, Cohen MH, Nordenberg A, Van Hare GF, Friedman RA, Perez M, Cecchin F, Schneider DS, Nehgme RA, Buyon JP. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37 (1): 238-242
15. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, Katholi MC, Buyon JP. Spectrum and progression of conduction abnormalities in infants born to mothers with anti- SSA/Ro-SSB/La antibodies. Lupus 2002; 11 (3): 145-151
16. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibodyassociated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42 (11): 2335-2345
17. Rein AJ, Mevorach D, Perles Z, Gavri S, Nadjari M, Nir A, Elchalal U. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram- based study. Circulation 2009; 119 (14): 1867-1872
18. Vesel S, Mazi U, Blejec T, Podnar T. First-degree heart block in the fetus of an anti-SSA/Ropositive mother: reversal after a short course of dexamethasone treatment. Arthritis Rheum 2004; 50 (7): 2223-6
19. Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexa - methasone Evaluation (PRIDE) prospective study. Circulation 2008; 117 (4): 485-493
20. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of firstdegree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004; 50 (4): 1253-1261
21. Boutjdir M, Chen L, Zhang ZH, Tseng CE, Di-Donato F, Rashbaum W, Morris A, el-Sherif N, Buyon JP. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80 (3): 354-362
22. Boutjdir M, Chen L, Zhang ZH, Tseng CE, El- Sherif N, Buyon JP. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 1998; 44 (1): 11-19
23. Mazel JA, El-Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999; 99 (14): 1914-1918
24. Restivo M, Kozhevnikov DO, Boutjdir M. Optical mapping of activation patterns in an animal model of congenital heart block. Am J Physiol Heart Circ Physiol 2001; 280 (4): H1889-1895
25. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004; 50 (10): 3187-3194
26. Gordon PA, Khamashta MA, Hughes GR, Rosenthal E. Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. Arthritis Rheum 2001; 44 (1): 242-243
27. Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004; 50 (4): 1248-1252
28. Lazzerini PE, Capecchi PL, Acampa M, Morozzi G, Bellisai F, Bacarelli MR, Dragoni S, Fineschi I, Simpatico A, Galeazzi M, Laghi-Pasini F. Anti-Ro/SSA-associated QTc interval prolongation in the adults: The role of antibody level and specificity. Arthritis Care Res 2011.
29. Lazzerini PE, Capecchi PL, Laghi-Pasini F. The "Invulnerability"of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardio - myocyte. J Cardiovasc Electrophysiol 2011; 22 (8): E88
30. Schwartz PJ, Montemerlo M, Facchini M, Salice P, Rosti D, Poggio G, Giorgetti R. The QT interval throughout the first 6 months of life: a prospective study. Circulation 1982; 66 (3): 496-501
31. Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Cattaneo R, Tincani A, Motta M, Doria A, Zulian F, Milanesi O, Brucato A, Riboldi P, Meroni PL. Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study. Rheumatology (Oxford) 2007; 46 (8): 1285-1289
32. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 2002; 39 (1): 130-137
33. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002; 40 (4): 796-802
34. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, Hamilton RM, Hornberger LK. Maternal anti-Ro and anti-La antibody- associated endocardial fibroelastosis. Circulation 2002; 105 (7): 843-848
35. Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000; 106 (1 Pt 1): 86-91
36. Guettrot-Imbert G, Cohen L, Fermont L, Villain E, Frances C, Thiebaugeorges O, Foliguet B, Leroux G, Cacoub P, Amoura Z, Piette JC, Costedoat-Chalumeau N. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies. J Rheumatol 38 (2): 378-386
37. Raboisson MJ, Fouron JC, Sonesson SE, Nyman M, Proulx F, Gamache S. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr 2005; 18 (4): 375-380
38. Pises N, Acherman RJ, Iriye BK, Rollins RC, Castillo W, Herceg E, Evans WN. Positive maternal anti-SSA/SSB antibody-related fetal right ventricular endocardial fibroelastosis without atrioventricular block, reversal of endocardial fibroelastosis. Prenat Diagn 2009; 29 (2): 177-178
39. Xiao GQ, Qu Y, Hu K, Boutjdir M. Down-regulation of L-type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits. FASEB J 2001; 15 (9): 1539-1545
40. Miranda-Carus ME, Boutjdir M, Tseng CE, Di-Donato F, Chan EK, Buyon JP. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 1998; 161 (11): 5886-5892
41. Suzuki H, Silverman ED, Wu X, Borges C, Zhao S, Isacovics B, Hamilton RM. Effect of maternal autoantibodies on fetal cardiac conduction: an experimental murine model. Pediatr Res 2005; 57 (4): 557-562
42. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thoren P, Herlenius E, Wahren- Herlenius M. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeo - stasis, and mediate congenital heart block. J Exp Med 2005; 201 (1): 11-17
43. Garcia S, Nascimento JH, Bonfa E, Levy R, Oliveira SF, Tavares AV, de Carvalho AC. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 1994; 93 (2): 718-724
44. Viana VS, Garcia S, Nascimento JH, Elkon KB, Brot N, Campos de Carvalho AC, Bonfa E. Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus 1998; 7 (3): 141-147
45. Horsfall AC, Venables PJ, Taylor PV, Maini RN. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4 (1): 165-176
46. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin VR, Wolfson-Reichlin M, Lee LA. Concentration of autoantibodies to native 60- kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994; 37 (11): 1698-1703
47. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179 (4): 1317-1330
48. Baboonian C, Venables PJ, Booth J, Williams DG, Roffe LM, Maini RN. Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol 1989; 78 (3): 454-459
49. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casiano CA, Di Donato F, Chan EK, Buyon JP. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998; 161 (9): 5061-5069
50. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50 (1): 173-182
51. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003; 171 (6): 3253-3261
52. Ucker DS. Death by suicide: one way to go in mammalian cellular development? New Biol 1991; 3 (2): 103-109
53. Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996; 236 (1): 1-26
54. Caricchio R, Reap EA, Cohen PL. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J Immunol 1998; 161 (1): 241-251
55. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macro phages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101 (4): 890-898
56. Clancy RM, Neufing PJ, Zheng P, O'Mahony M, Nimmerjahn F, Gordon TP, Buyon JP. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006; 116 (9): 2413-2422
57. Clancy RM, Askanase AD, Kapur RP, Chiopelas E, Azar N, Miranda-Carus ME, Buyon JP. Transdifferentiation of cardiac fibro - blasts, a fetal factor in anti-SSA/Ro-SSB/La antibody- mediated congenital heart block. J Immunol 2002; 169 (4): 2156-2163
58. Clancy RM, Buyon JP. Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis. J Leukoc Biol 2003; 74 (6): 959-960
59. Briassouli P, Komissarova EV, Clancy RM, Buyon JP. Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block. Circ Res 107 (3): 374-387
60. Buyon JP, Slade SG, Reveille JD, Hamel JC, Chan EK. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome. J Immunol 1994; 152 (7): 3675-3684
61. Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005; 52 (10): 3079-3086
62. Eftekhari P, Salle L, Lezoualc'h F, Mialet J, Gastineau M, Briand JP, Isenberg DA, Fournie GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 2000; 30 (10): 2782-2790
63. Alvarez D, Briassouli P, Clancy RM, Zavadil J, Reed JH, Abellar RG, Halushka M, Fox-Talbot K, Barrat FJ, Buyon JP. A novel role of endothelin-1 in linking TLR7-mediated inflammation to fibrosis in congenital heart block. J Biol Chem
64. Horsfall AC, Rose LM. Cross-reactive maternal autoantibodies and congenital heart block. J Autoimmun 1992; 5: 479-493
65. Orth T, Dorner T, Meyer Zum Buschenfelde KH, Mayet WJ. Complete congenital heart block is associated with increased autoantibody titers against calreticulin. Eur J Clin Invest 1996; 26 (3): 205-215
66. Llanos C, Chan EK, Li S, Abadal GX, Izmirly P, Byrne C, Clancy RM, Buyon JP. Antibody reactivity to alpha-enolase in mothers of children with congenital heart block. J Rheumatol 2009; 36 (3): 565-569
67. Qu Y, Baroudi G, Yue Y, Boutjdir M. Novel molecular mechanism involving alpha1D (Cav1.3) L-type calcium channel in autoimmune-associated sinus bradycardia. Circulation 2005; 111 (23): 3034-3041
68. Qu Y, Xiao GQ, Chen L, Boutjdir M. Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. J Mol Cell Cardiol 2001; 33 (6): 1153-1163
69. Xiao GQ, Hu K, Boutjdir M. Direct inhibition of expressed cardiac L- and T-type calcium channels by igg from mothers whose children have congenital heart block. Circulation 2001; 103 (11): 1599-1604
70. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993; 82 (1): 11-16
71. Guo J, Ono K, Noma A. A sustained inward current activated at the diastolic potential range in rabbit sino-atrial node cells. J Physiol 1995; 483 (Pt 1): 1-13
72. Noble D. The surprising heart: a review of recent progress in cardiac electrophysiology. J Physiol 1984; 353: 1-50
73. Mitsuiye T, Shinagawa Y, Noma A. Sustained inward current during pacemaker depolarization in mammalian sinoatrial node cells. Circ Res 2000; 87 (2): 88-91
74. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990; 96 (1): 195-215
75. Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 2000; 102 (1): 89-97
76. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat N. Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 2002; 90 (9): 981-987
77. Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 2003; 100 (9): 5543-5548
78. Mancarella S, Yue Y, Karnabi E, Qu Y, El-Sherif N, Boutjdir M. Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse. Am J Physiol Heart Circ Physiol 2008; 295 (5): H2017-2024
79. Qu Y, Karnabi E, Ramadan O, Yue Y, Chahine M, Boutjdir M. Perinatal and postnatal expression of Cav1.3 alpha1D Ca(2) channel in the rat heart. Pediatr Res 69 (6): 479-484
80. Karnabi E, Qu Y, Wadgaonkar R, Mancarella S, Yue Y, Chahine M, Clancy RM, Buyon JP, Boutjdir M. Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) Ltype Ca channel. J Autoimmun 34 (2): 80-86
81. Muth JN, Yamaguchi H, Mikala G, Grupp IL, Lewis W, Cheng H, Song LS, Lakatta EG, Varadi G, Schwartz A. Cardiac-specific overexpression of the alpha(1) subunit of the L-type voltage- dependent Ca(2+) channel in transgenic mice. Loss of isoproterenol-induced contraction. J Biol Chem 1999; 274 (31): 21503-21506
82. Karnabi E, Qu Y, Mancarella S, Boutjdir M. Rescue and Worsening of Congenital Heart Block- Associated Electrocardiographic Abnormalities in Two Transgenic Mice. J Cardiovasc Electrophysiol
83. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332 (22): 1467-1474